Showing results (1-10 of 125) with videos related to
Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|April 29, 1998
Tumor immunotherapy: cytokines and antigen presentationE M Lord, J G FrelingerImmunology|August 14, 1999
Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cellsE Storozynsky, J G Woodward, J G Frelinger, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumorT M Blieden, A J McAdam, J G Frelinger, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfectionD W Bahler, J G Frelinger, L W Harwell, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
Molecular analysis of deficient class I H-2 antigen expression by mouse lung carcinoma cellsD W Bahler, K M Cerosaletti, E M Lord, et al.European Journal of Immunology|September 1, 1992
CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell cloneA J McAdam, T M Blieden, J G Frelinger, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
Two regions of the H-2 Dd promoter are responsive to dimethylsulfoxide in line 1 cells by a mechanism distinct from IFN-gammaK M Cerosaletti, J G Woodward, E M Lord, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1988
Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigensG Dennert, C Landon, E M Lord, et al.Immunology|May 1, 2001
Tumours can act as adjuvants for humoral immunityD M Brown, T L Fisher, C Wei, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
IL-3-mediated enhancement of particulate antigen presentation by macrophagesE M Lord, K Y Yeh, J A Moran, et al.Pageof 13